No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
KZIA Kazia Therapeutics
- 0.896
- -0.344-27.76%
Close Jul 12 16:00 ET
- 0.840
- -0.056-6.23%
Post 19:59 ET
26.69MMarket Cap-2376P/E (TTM)
1.105High0.861Low25.62MVolume1.070Open1.240Pre Close24.88MTurnover96.71%Turnover RatioLossP/E (Static)29.79MShares1.58052wk High7.47P/B23.73MFloat Cap0.18752wk Low--Dividend TTM26.49MShs Float15.850Historical High--Div YieldTTM19.67%Amplitude0.187Historical Low0.971Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Why ASP Isotopes Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of ASP Isotopes Inc. (NASDAQ:ASPI) fell during Friday's session after the company announced pricing of a $30 million public offering of 12 million shares at $2.50 per share.ASP Isotopes
Nasdaq Surges 1%; JPMorgan Posts Upbeat Earnings
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Friday.The Dow traded up 0.85% to 40,090.44 while the NASDAQ rose 1.01% to 18,467.26. The S&P 500
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Dow Jumps 100 Points; Producer Inflation Surpasses Expectations For June
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 100 points on Friday.Following the market opening Friday, the Dow traded up 0.25% to 39,853.88 while the NASDAQ rose 0.2
HC Wainwright & Co. Reiterates Buy on Kazia Therapeutics, Maintains $2 Price Target
HC Wainwright & Co. analyst Sean Lee reiterates Kazia Therapeutics with a Buy and maintains $2 price target.
Kazia Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/12/2024 103.85% HC Wainwright & Co. $2 → $2 Reiterates Buy → Buy 04/11/2023 103.85% HC Wainwright & Co.
Comments
Follow Our Official Telegram tynkrlab
The $Dow Jones Industrial Average(.DJI.US$surged to a new record, closing up 247.15 points (0.62%) at 40,000.90. The $S&P 500 Index(.SPX.US$ and $Nasdaq Composite Index(.IXIC.US$ also saw gains of 0.55% and 0.63% respectively. This rally was driven by positive investor sentiment despite mixed economic signals.
Key Stock Movements
• eVTOL Stocks: $Joby Aviation(JOBY.US$ soared nearly 28% and $Archer Aviation(ACHR.US$ rose over...
The $Dow Jones Industrial Average(.DJI.US$surged to a new record, closing up 247.15 points (0.62%) at 40,000.90. The $S&P 500 Index(.SPX.US$ and $Nasdaq Composite Index(.IXIC.US$ also saw gains of 0.55% and 0.63% respectively. This rally was driven by positive investor sentiment despite mixed economic signals.
Key Stock Movements
• eVTOL Stocks: $Joby Aviation(JOBY.US$ soared nearly 28% and $Archer Aviation(ACHR.US$ rose over...
6
Kazia Therapeutics Announces Phase II/III Clinical Trial Results for Paxalisib in Glioblastoma.
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...
Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, has recently announced findings from a Phase II/III clinical trial evaluating their novel drug, paxalisib, for the treatment of glioblastoma. Glioblastoma is a highly aggressive and life-threatening brain cancer, representing one of th...
1
$Kazia Therapeutics(KZIA.US$ okay i double down next week
2
$Kazia Therapeutics(KZIA.US$ Let's Go Kazia!!!
1
$Kazia Therapeutics(KZIA.US$ Gettimg back on!
1
4
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg